Versartis Inc (NASDAQ:VSAR)’s Trend Unknown, Especially After Increased Shorts

June 14, 2018 - By Mona Holcomb

Investors sentiment decreased to 0.5 in 2018 Q1. Its down 0.01, from 0.51 in 2017Q4. It dropped, as 17 investors sold Versartis, Inc. shares while 29 reduced holdings. 9 funds opened positions while 14 raised stakes. 13.21 million shares or 22.48% less from 17.05 million shares in 2017Q4 were reported.
Tower Rech Cap Llc (Trc) reported 0% in Versartis, Inc. (NASDAQ:VSAR). State Of Wisconsin Invest Board has invested 0% in Versartis, Inc. (NASDAQ:VSAR). 51,575 are owned by Deutsche Bankshares Ag. Renaissance Tech Ltd Limited Liability Company holds 0% of its portfolio in Versartis, Inc. (NASDAQ:VSAR) for 61,900 shares. Bridgeway Cap Mgmt stated it has 0% of its portfolio in Versartis, Inc. (NASDAQ:VSAR). Tudor Investment Corp Et Al holds 12,765 shares or 0% of its portfolio. Millennium Management Limited Liability reported 538,240 shares stake. Los Angeles Capital & Equity holds 0% or 30,311 shares in its portfolio. Gsa Capital Prtnrs Llp reported 0.01% of its portfolio in Versartis, Inc. (NASDAQ:VSAR). Goldman Sachs Grp invested 0% of its portfolio in Versartis, Inc. (NASDAQ:VSAR). 273,422 were reported by Aqr Capital Mgmt Limited Liability Company. Meeder Asset Management reported 1,510 shares stake. Spark Investment Mgmt Limited Liability Company has invested 0.01% in Versartis, Inc. (NASDAQ:VSAR). Bb&T Llc invested 0% in Versartis, Inc. (NASDAQ:VSAR). Amer Intl Group Inc has 0% invested in Versartis, Inc. (NASDAQ:VSAR).

Since March 23, 2018, it had 1 insider buy, and 3 insider sales for $1.89 million activity. $7,604 worth of stock was sold by Woody Tracy M on Friday, March 23. Stout Jay S sold $7,524 worth of stock. Shares for $13,848 were sold by Shepard Jay on Tuesday, May 22.

The stock of Versartis Inc (NASDAQ:VSAR) registered an increase of 8.75% in short interest. VSAR’s total short interest was 2.30M shares in June as published by FINRA. Its up 8.75% from 2.12M shares, reported previously. With 300,500 shares average volume, it will take short sellers 8 days to cover their VSAR’s short positions. The short interest to Versartis Inc’s float is 7.33%.

The stock increased 7.14% or $0.15 during the last trading session, reaching $2.25. About 716,851 shares traded or 17.89% up from the average. Versartis, Inc. (NASDAQ:VSAR) has declined 91.00% since June 14, 2017 and is downtrending. It has underperformed by 103.57% the S&P500.

Versartis, Inc. operates as an endocrine-focused biopharmaceutical firm in the United States. The company has market cap of $81.18 million. The firm is developing VRS-317, a long-acting recombinant human growth hormone, which is in Phase III clinical trials for the treatment of growth hormone deficiency. It currently has negative earnings. It develops drug candidates that it has licensed from Amunix Operating, Inc.

Another recent and important Versartis, Inc. (NASDAQ:VSAR) news was published by which published an article titled: “Pre-Open Movers 06/04: (VSAR) (VYGR) (GHDX) Higher; (NKTR) (JNCE) (CFX) Lower (more…)” on June 04, 2018.

Versartis, Inc. (NASDAQ:VSAR) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: